Rich McCloud is a Director for Business Analytics and Insights, supporting the Pfizer Biosimilars portfolio. Rich has over 15 years of pharmaceutical market research and consulting experience, including strategy development, HCP positioning and messaging, DTC campaign development, and forecasting. Rich started his career in pharmaceuticals in 1999 at ZS Associates, and moved on to Pfizer where he held roles supporting project teams including Lyrica, Vfend, Celebrex and Bextra. Rich joined Genentech in 2007, where he gained biologics and respiratory therapy area experience working on Xolair. He embarked as a consultant, and worked primarily with Eli Lilly where he launched the fibromyalgia indication, and developed the very successful DTC campaigns for the chronic pain and depression indications. Rich returned to New York and Pfizer in 2009 to work on Lyrica, and recently joined the Biosimilars team in 2013. Rich earned a bachelor’s degree in Business Administration from Florida A&M University, and a Master’s degree in market research from University of Georgia. He currently resides in Jersey City, NJ, and is the proud father of his daughter, Lillian.